Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zuck

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Advances in Therapy|December 9, 1995
Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial GroupJ Piquet, P Zuck, G Dennewald, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentR Finch, D Schürmann, O Collins, et al.
Medecine Et Maladies Infectieuses|October 13, 2009
[Relevance of fluoroquinolone use in Lorraine: results of the first survey]T Doco-Lecompte, B Demoré, C Burty, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Advances in Therapy|December 9, 1995
Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial GroupJ Piquet, P Zuck, G Dennewald, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentR Finch, D Schürmann, O Collins, et al.
Medecine Et Maladies Infectieuses|October 13, 2009
[Relevance of fluoroquinolone use in Lorraine: results of the first survey]T Doco-Lecompte, B Demoré, C Burty, et al.
Pageof 4